4//SEC Filing
BIOSPECIFICS TECHNOLOGIES CORP 4
Accession 0001062993-14-006718
CIK 0000875622operating
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:44 PM ET
Size
7.5 KB
Accession
0001062993-14-006718
Insider Transaction Report
Form 4
Schamroth Michael
Director
Transactions
- Sale
Common Stock, $0.001 par value
2014-11-12$39.00/sh−2,000$78,000→ 43,000 total - Sale
Common Stock, $0.001 par value
2014-11-13$39.47/sh−2,200$86,830→ 40,800 total - Sale
Common Stock, $0.001 par value
2014-11-14$39.00/sh−1,000$39,000→ 39,800 total
Footnotes (1)
- [F1]The selling price of $39.4682 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $39.465 to $39.50. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875622
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:44 PM ET
- Size
- 7.5 KB